Here: 3 questions that challenge your acumen about the latest AAN guidelines on sudden unexplained death in epilepsy.
Epilepsy and Seizure
New studies shed light on topics such as nonencephalic pain and headache chronicity; benign childhood epilepsy with centrotemporal spikes and social cognition; and causal triggers of Alzheimer disease onset.
What do the new AAN guidelines on SUDEP offer? Here’s a quick overview of the key facts.
Is it a seizure or something else? Here are 5 tips to assess and treat psychogenic non-epileptic seizures.
The conventional classification of seizure types needed a makeover. To employ the 2017 ILAE classification, a clinician should follow some general rules.
Which came first? Epilepsy or depression? The author sheds light on a complex relationship.
New findings may have an impact on reducing the epilepsy disease burden in future generations.
The anticonvulsant known as Potiga (ezogabine) in the US and as Trobalt (retigabine) in Europe will be discontinued by the manufacturer at the end of June. Details here.
Here’s evidence that ALF may be an important memory disorder in subgroups of patients with epilepsy.
Here is new evidence that the incidence of SUDEP is higher than expected in boys, people with psychiatric comorbidities, and other groups. Details here.